Casey Quinlan
Breast Cancer VACCINE! No, I’m NOT Kidding.
Cancer for Christmas: Making the Most of a Daunting Gift
Dr. Brian Czerniecki at the University of Pennsylvania has developed an immune-therapy treatment for ductal carcinoma in situ (DCIS) HER-2/neu. Yes, kids, that’s a vaccine, as well as treatment for DCIS HER-2/neu. The immune-therapy/vaccine has been in limited trials at... UPenn since 2004. An Oncolink interview with Dr. Czerniecki about the first clinical trial is here. A second trial is still ongoing – if you or anyone you know has been diagnosed with DCIS HER-2/neu, visit this link to find out how they might participate in the trial. Here’s a video of Dr. Czerniecki talking about his work: The really exciting part of this isn’t just the possibility of ending HER-2/neu breast cancer. It’s that HER proteins are the bad guys in many types of aggressive cancer: ovarian, stomach, and uterine. Dr. Czerniecki and his team are working on immune therapy for hormone-positive breast cancer (the type I had), and I plan on being near the front of the line when it’s available. Czerniecki might be the Jonas Salk of the 21st century, partly because he doesn’t want to partner with drug companies to fund his FDA trial. The Pennies In Action website gives information on how to help fund the trial. Know any gazillionaires with a cancer history in their family? Ask them if a $1M investment (or more) would be worth it to them…
Published:6 May 2010, 6:57 am
More:Read more stories
Subscribe:Subscribe to stories from this Profile
Profile:Visit my Profile
See More
Yesterday at 2:23pm via Social RSS · Comment · UnlikeLike · View Feedback (7)Hide Feedback (7) · Share
You, Casey Quinlan and 3 others like this.
Shelley McAtee Dodt
Shelley McAtee Dodt
I know for sure it works! I was a trial participant! 6 wks, 6 shots and my cancer was gone! I had no side effects!
Yesterday at 3:13pm
Uschi Keszler
Uschi Keszler
do yourself a favor and find out about this. You never know when you or a loved one needs it....
8 hour
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment